Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study

To expand our understanding of the role of angiotensin II (ANGII) in coronavirus infectious disease 2019 (COVID‐19), we conducted an international, multicenter registry study to assess the use of ANGII in patients with COVID‐19 compared to patients not receiving ANGII. Critically ill adult patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Serpa Neto, Ary, Landoni, Giovanni, Ostermann, Marlies, Lumlertgul, Nuttha, Forni, Lui, Alvarez‐Belon, Lucas, Trapani, Tony, Alliegro, Patricia V., Zacharowski, Kai, Wiedenbeck, Carolin, de Backer, Daniel, Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015246/
https://www.ncbi.nlm.nih.gov/pubmed/35029318
http://dx.doi.org/10.1002/jmv.27592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015246/
https://www.ncbi.nlm.nih.gov/pubmed/35029318
http://dx.doi.org/10.1002/jmv.27592

Ejemplares similares